WSB2 is frequently overexpressed in cancers such as lung, breast, and melanoma, where it promotes malignancy by driving cell proliferation, cycle progression, and migration (Zhang et al., 2019; Ma et al., 2020). The gene discussed is WSB2; the disease is cancer.